gemfibrozil has been researched along with Basedow Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonelli, A | 1 |
| Ferrari, SM | 1 |
| Frascerra, S | 1 |
| Pupilli, C | 1 |
| Mancusi, C | 1 |
| Metelli, MR | 1 |
| Orlando, C | 1 |
| Ferrannini, E | 1 |
| Fallahi, P | 1 |
1 other study available for gemfibrozil and Basedow Disease
| Article | Year |
|---|---|
CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes.
Topics: Adult; Chemokine CXCL11; Chemokine CXCL9; Cytokines; Female; Fenofibrate; Gemfibrozil; Graves Diseas | 2010 |